chronic myeloproliferative disorder: A clonal hematopoietic stem cell disorder, characterized by proliferation in the bone marrow of one or more of the myeloid (i.e., granulocytic, erythroid, megakaryocytic, and mast cell) lineages. It is primarily a neoplasm of adults. (WHO 2008)
Filter registries Inpat., Oupat., Death
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
POLYCYTVERA
Extra metadata
List of similar endpoints to
Polycythaemia vera
based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
None
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 483 | 244 | 239 |
| Unadjusted prevalence (%) | 0.19 | 0.17 | 0.21 |
| Mean age at first event (years) | 61.65 | 61.76 | 61.53 |
| Follow-up | Absolute risk | HR [95% CI] | p | N |
|---|---|---|---|---|
| 1998–2019 | 0.05 | 3.36 [1.58, 7.15] | 1.6e-3 | 84 |
| 15 years | 0.03 | 4.43 [2.35, 8.36] | 4.3e-6 | 79 |
| 5 years | 0.01 | 6.17 [3.82, 9.97] | 1.0e-13 | 35 |
| 1 year | - | - | - | - |
Index endpoint: POLYCYTVERA – Polycythaemia vera
GWS hits: 8
before Polycythaemia vera
after Polycythaemia vera
Loading survival analyses plot
Loading survival analyses table